Literature DB >> 13182600

Antiserum in the prophylaxis of rabies.

K HABEL.   

Abstract

This paper reviews recent experimental evidence in support of inoculation with antirabies serum, the value of which, as a prophylactic measure, is compared with that of vaccine treatment alone. The author concludes that the chief advantages of combined antiserum-vaccine prophylaxis lie in the rapid treatment of cases who have suffered severe exposure, and in the possibility of reducing the incidence of post-vaccinal complications.

Keywords:  IMMUNE SERUMS/therapeutic use; RABIES/therapy

Mesh:

Substances:

Year:  1954        PMID: 13182600      PMCID: PMC2542175     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Recent developments in the prophylaxis of rabies.

Authors:  H KOPROWSKI; H R COX
Journal:  Am J Public Health Nations Health       Date:  1951-12

2.  Use of hyperimmune anti-rabies serum concentrates in experimental rabies.

Authors:  H KOPROWSKI; J VAN DER SCHEER; J BLACK
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

  2 in total
  5 in total

1.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3.

Authors:  P ATANASIU; D A CANNON; D J DEAN; J P FOX; K HABEL; M M KAPLAN; R E KISSLING; H KOPROWSKI; P LEPINE; F PEREZ GALLARDO
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 2.  The vaccination of man and other animals against rabies.

Authors:  J Crick
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

3.  Studies on the local treatment of wounds for the prevention of rabies.

Authors:  M M KAPLAN; D COHEN; H KOPROWSKI; D DEAN; L FERRIGAN
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

4.  Rapidity and magnitude of antibody response to duck-embryo rabies vaccine administered as a pre-exposure regimen.

Authors:  P R Schnurrenberger; G R Anderson; J H Russell
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

5.  Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.

Authors:  Paola De Benedictis; Andrea Minola; Elena Rota Nodari; Roberta Aiello; Barbara Zecchin; Angela Salomoni; Mathilde Foglierini; Gloria Agatic; Fabrizia Vanzetta; Rachel Lavenir; Anthony Lepelletier; Emma Bentley; Robin Weiss; Giovanni Cattoli; Ilaria Capua; Federica Sallusto; Edward Wright; Antonio Lanzavecchia; Hervé Bourhy; Davide Corti
Journal:  EMBO Mol Med       Date:  2016-04-01       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.